Rajesh Kumar's Stock Ratings

HSBC Analyst

Rajesh Kumar is an analyst at HSBC. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/16/2024

Overall Average Return

16.5%

Smart Score

71.5%

Overall Average Return Percentile

74th

Number of Ratings

17
Buy NowGet Alert
04/30/2024TMOBuy Now
Thermo Fisher Scientific
$597.1512.2%$660 → $670MaintainsBuyGet Alert
04/17/2024TMOBuy Now
Thermo Fisher Scientific
$597.1510.52%$630 → $660MaintainsBuyGet Alert
04/17/2024DHRBuy Now
Danaher
$264.845.72%$250 → $280UpgradeHold → BuyGet Alert
04/04/2024UNHBuy Now
UnitedHealth Group
$521.27-11.75% → $460UpgradeReduce → HoldGet Alert
12/18/2023DHRBuy Now
Danaher
$264.84——Initiates → HoldGet Alert
12/18/2023TEVABuy Now
Teva Pharmaceutical Indus
$16.40-20.73% → $13Initiates → BuyGet Alert
12/18/2023TMOBuy Now
Thermo Fisher Scientific
$597.152.15% → $610Initiates → BuyGet Alert
12/18/2023ABBVBuy Now
AbbVie
$164.35-5.08%$167 → $156DowngradeBuy → HoldGet Alert
12/18/2023UNHBuy Now
UnitedHealth Group
$521.27-7.92%$550 → $480DowngradeHold → ReduceGet Alert
10/27/2023BMYBuy Now
Bristol-Myers Squibb
$44.1520.05%$55 → $53UpgradeReduce → HoldGet Alert
07/14/2023MRNABuy Now
Moderna
$132.60-26.85% → $97Initiates → ReduceGet Alert
07/14/2023BNTXBuy Now
BioNTech
$92.1434.58% → $124Initiates → BuyGet Alert
07/14/2023PFEBuy Now
Pfizer
$28.9972.47% → $50Initiates → BuyGet Alert
07/14/2023MRKBuy Now
Merck & Co
$130.88-6.02% → $123Initiates → HoldGet Alert
07/14/2023LLYBuy Now
Eli Lilly
$771.12-27.38% → $560Initiates → BuyGet Alert
07/14/2023BMYBuy Now
Bristol-Myers Squibb
$44.1526.84% → $56Initiates → ReduceGet Alert
07/14/2023ABBVBuy Now
AbbVie
$164.351.61% → $167Initiates → BuyGet Alert

Recent Analyst Stock Rating News

7 Analysts Assess Thermo Fisher Scientific: What You Need To Know
Forecasting The Future: 7 Analyst Projections For Danaher
The Analyst Verdict: UnitedHealth Group In The Eyes Of 11 Experts
8 Analysts Assess Teva Pharmaceutical Indus: What You Need To Know
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
What Analysts Are Saying About UnitedHealth Group Stock
Beyond The Numbers: 8 Analysts Discuss Teva Pharmaceutical Indus Stock
Breaking Down Thermo Fisher Scientific: 5 Analysts Share Their Views
Breaking Down AbbVie: 7 Analysts Share Their Views
In-Depth Examination Of 4 Analyst Recommendations For Teva Pharmaceutical Indus
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free